Beth L Nordstrom

Summary

Affiliation: Ingenix Epidemiology
Country: USA

Publications

  1. ncbi request reprint Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir
    Beth L Nordstrom
    Ingenix Epidemiology, Auburndale, MA 02466, USA
    Curr Med Res Opin 21:761-8. 2005
  2. ncbi request reprint Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study
    Beth L Nordstrom
    Ingenix Epidemiology, Auburndale, Mass, USA
    Antivir Ther 9:187-95. 2004
  3. ncbi request reprint Persistence and adherence with topical glaucoma therapy
    Beth L Nordstrom
    Ingenix Epidemiology, Auburndale, Massachusetts 02466, USA
    Am J Ophthalmol 140:598-606. 2005
  4. ncbi request reprint Health outcomes among patients receiving oseltamivir
    Cheryl Enger
    Ingenix Epidemiology, Auburndale, MA 02466, USA
    Pharmacoepidemiol Drug Saf 13:227-37. 2004
  5. ncbi request reprint The impact of wording in "Dear doctor" letters and in black box labels
    Lisa Bianchi Weatherby
    Epidemiology Division, Ingenix, Newton, MA 02466, USA
    Clin Pharmacol Ther 72:735-42. 2002
  6. ncbi request reprint Identification of abacavir hypersensitivity reaction in health care claims data
    Beth L Nordstrom
    i3 Drug Safety, Auburndale, MA, USA
    Pharmacoepidemiol Drug Saf 16:289-96. 2007

Detail Information

Publications6

  1. ncbi request reprint Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir
    Beth L Nordstrom
    Ingenix Epidemiology, Auburndale, MA 02466, USA
    Curr Med Res Opin 21:761-8. 2005
    ..Clinical trials suggest that the risk of pneumonia and other sequelae of influenza may be reduced in patients using oseltamivir...
  2. ncbi request reprint Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study
    Beth L Nordstrom
    Ingenix Epidemiology, Auburndale, Mass, USA
    Antivir Ther 9:187-95. 2004
    ..It is concluded that oseltamivir use does not appear to be associated with an increased risk of skin reactions...
  3. ncbi request reprint Persistence and adherence with topical glaucoma therapy
    Beth L Nordstrom
    Ingenix Epidemiology, Auburndale, Massachusetts 02466, USA
    Am J Ophthalmol 140:598-606. 2005
    ..The present study describes the patterns and predictors of treatment persistence and adherence among patients who are diagnosed with glaucoma or as glaucoma suspects (based on claims codes)...
  4. ncbi request reprint Health outcomes among patients receiving oseltamivir
    Cheryl Enger
    Ingenix Epidemiology, Auburndale, MA 02466, USA
    Pharmacoepidemiol Drug Saf 13:227-37. 2004
    ..Oseltamivir was approved by the FDA for the treatment of influenza in 1999. The primary objective was to compare health outcomes among influenza patients who were treated with oseltamivir and those who were not...
  5. ncbi request reprint The impact of wording in "Dear doctor" letters and in black box labels
    Lisa Bianchi Weatherby
    Epidemiology Division, Ingenix, Newton, MA 02466, USA
    Clin Pharmacol Ther 72:735-42. 2002
    ....
  6. ncbi request reprint Identification of abacavir hypersensitivity reaction in health care claims data
    Beth L Nordstrom
    i3 Drug Safety, Auburndale, MA, USA
    Pharmacoepidemiol Drug Saf 16:289-96. 2007
    ..Identification of this reaction through medical insurance claims could provide a simple and efficient means of monitoring the incidence of abacavir hypersensitivity in large populations of patients...